Transcervical tubal sterilization. Transcervical sterilization or tubal occlusion is a procedure that offers permanent birth control for women. It is a highly effective, minimally invasive alternative to surgical tubal ligation.

The global Transcervical Tubal Sterilization market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Transcervical Tubal Sterilization volume and value at global level, regional level and company level. From a global perspective, this report represents overall Transcervical Tubal Sterilization market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Transcervical Tubal Sterilization in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Transcervical Tubal Sterilization manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Ethicon
Medtronic
Karl Storz
Olympus
Applied Medical
Richard Wolf
Bayer AG
Stryker
B. Braun Aesculap
ERBE
LiNA Medical
ConMed
Microline Surgical
Apollo Endosurgery

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Tubal Ligation
Transcervical Implant

Segment by Application
Hospital
Clinic